Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models

References

• Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 2002; 27:552 - 8; http://dx.doi.org/10.1016/S0968-0004(02)02177-1; PMID: 12417130
   PubMed Web of Science ®Google Scholar
• Luvisetto S, Rossetto O, Montecucco C, Pavone F. Toxicity of botulinum neurotoxins in central nervous system of mice. Toxicon 2003; 41:475 - 81; http://dx.doi.org/10.1016/S0041-0101(02)00370-7; PMID: 12657317
   PubMed Web of Science ®Google Scholar
• Smith LA. Botulism and vaccines for its prevention. Vaccine 2009; 27:Suppl 4 D33 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.08.059; PMID: 19837283
   PubMed Web of Science ®Google Scholar
• Froude JW, Stiles B, Pelat T, Thullier P. Antibodies for biodefense. MAbs 2011; 3:517 - 27; http://dx.doi.org/10.4161/mabs.3.6.17621; PMID: 22123065
   PubMed Web of Science ®Google Scholar
• Shimizu M, Nagashima H, Sano K, Hashimoto K, Ozeki M, Tsuda K, Hatta H. Molecular stability of chicken and rabbit immunoglobulin G. Biosci Biotechnol Biochem 1992; 56:270 - 4; http://dx.doi.org/10.1271/bbb.56.270; PMID: 1368302
   PubMed Web of Science ®Google Scholar
• Spillner E, Braren I, Greunke K, Seismann H, Blank S, du Plessis D. Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy. Biologicals 2012; 40:313 - 22; http://dx.doi.org/10.1016/j.biologicals.2012.05.003; PMID: 22748514
   PubMed Web of Science ®Google Scholar
• Dias da Silva W, Tambourgi DV. IgY: a promising antibody for use in immunodiagnostic and in immunotherapy. Vet Immunol Immunopathol 2010; 135:173 - 80; http://dx.doi.org/10.1016/j.vetimm.2009.12.011; PMID: 20083313
   PubMed Web of Science ®Google Scholar
• Xu Y, Li X, Jin L, Zhen Y, Lu Y, Li S, You J, Wang L. Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: a review. Biotechnol Adv 2011; 29:860 - 8; http://dx.doi.org/10.1016/j.biotechadv.2011.07.003; PMID: 21787857
   PubMed Web of Science ®Google Scholar
• Trott DL, Yang M, Gonzalez J, Larson AE, Tepp WH, Johnson EA, Cook ME. Egg yolk antibodies for detection and neutralization of Clostridium botulinum type A neurotoxin. J Food Prot 2009; 72:1005 - 11; PMID: 19517727
   PubMed Web of Science ®Google Scholar
• Zhao Y, Kang L, Gao S, Gao X, Xin W, Wang J. PEG precipitation coupled with chromatography is a new and sufficient method for the purification of botulinum neurotoxin type B [corrected]. [corrected] PLoS One 2012; 7:e39670; http://dx.doi.org/10.1371/journal.pone.0039670; PMID: 22761863
   PubMedGoogle Scholar
• Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, Johnson E, Smith L, Aoki KR, Dolly JO. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 2003; 278:1363 - 71; http://dx.doi.org/10.1074/jbc.M209821200; PMID: 12381720
   PubMed Web of Science ®Google Scholar
• Schade R, Calzado EG, Sarmiento R, Chacana PA, Porankiewicz-Asplund J, Terzolo HR. Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. Altern Lab Anim 2005; 33:129 - 54; PMID: 16180988
   PubMed Web of Science ®Google Scholar
• Karalewitz AP, Barbieri JT. Vaccines against botulism. Curr Opin Microbiol 2012; 15:317 - 24; http://dx.doi.org/10.1016/j.mib.2012.05.009; PMID: 22694934
   PubMed Web of Science ®Google Scholar
• Dembek ZF, Smith LA, Rusnak JM. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med Public Health Prep 2007; 1:122 - 34; http://dx.doi.org/10.1097/DMP.0b013e318158c5fd; PMID: 18388640
   PubMed Web of Science ®Google Scholar
• Hirai K, Arimitsu H, Umeda K, Yokota K, Shen L, Ayada K, Kodama Y, Tsuji T, Hirai Y, Oguma K. Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera. Acta Med Okayama 2010; 64:163 - 70; PMID: 20596127
   PubMed Web of Science ®Google Scholar
• Chen C, Wang S, Wang H, Mao X, Zhang T, Ji G, Shi X, Xia T, Lu W, Zhang D, et al. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain. PLoS One 2012; 7:e43845; http://dx.doi.org/10.1371/journal.pone.0043845; PMID: 22952786
   PubMed Web of Science ®Google Scholar
• Yu YZ, Sun ZW, Wang S, Yu WY. High-level expression of the Hcc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli and its immunogenicity as an antigen. Sheng Wu Gong Cheng Xue Bao 2007; 23:812 - 7; http://dx.doi.org/10.1016/S1872-2075(07)60052-1; PMID: 18051857
   PubMedGoogle Scholar
• Wang Q, Hou XJ, Cai K, Li T, Liu YN, Tu W, Xiao L, Bao SZ, Shi J, Gao X, et al. Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models. Can J Microbiol 2010; 56:1003 - 10; http://dx.doi.org/10.1139/W10-087; PMID: 21164570
   PubMed Web of Science ®Google Scholar
• Mukamoto M, Maeda H, Kohda T, Nozaki C, Takahashi M, Kozaki S. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E. Jpn J Infect Dis 2013; 66:46 - 50; http://dx.doi.org/10.7883/yoken.66.46; PMID: 23429085
   PubMed Web of Science ®Google Scholar
• Jones RG, Corbel MJ, Sesardic D. A review of WHO International Standards for botulinum antitoxins. Biologicals 2006; 34:223 - 6; http://dx.doi.org/10.1016/j.biologicals.2005.11.009; PMID: 16490362
   PubMed Web of Science ®Google Scholar